Nanopath
CAMBRIDGE, MA · Founded 2019 · CIK 0001940981 · Medtech · Private
Molecular diagnostic platform using nanotechnology for disease detection
nanopathdx.com →- Grants
- $1.8M
- 2 awards
- Sector median: 1
- Raised
- $15M
- 2 Form D · Feb 2025
- 20 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 33
- 3 granted · 30 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Integrated Point-of-Care System for Rapid Pathogen Identification in Urinary Tract Infections | $255,874 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Integrated Point-of-Care System for Rapid Pathogen Identification and Characterization | $1,497,781 | |
| Private capital raised | Form D · SEC | $5,341,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1472 | MAINELY SENSORS, LLC | — | — |
| 1473 | Novasenta Inc. | — | $25M |
| 1474 | Neurosity, Inc. | — | $5.0M |
| 1475 | Nanopath | — | $15M |
| 1476 | BoldHue, Inc. | — | $3.4M |
| 1477 | Pacegenix, Inc. | — | $23M |
| 1478 | Peak Mind Inc. | — | $20K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alison BurklundDirector · Executive Officer
- Jeff CroweDirector
- Jeffrey CroweDirector
- Aaron SandoskiDirector
- Amogha TadimetyDirector · Executive Officer
Patents
- Multiplexed Pathogen Detection Using Nanoplasmonic Sensor For Urinary Tract Infectionsapplication
- Multiplexed Pathogen Detection Using Nanoplasmonic Sensor For Human Papillomavirusapplication
- Apparatus For Detection Of Analytesapplication
- Light Guide Plate With Metallized Pixels For Light Extraction In Solar Signsapplication
- Transparent Illumination Photolithography Methods And Systemsgranted
- Maskless Photolithography Devices, Methods, And Systemsapplication
- Maskless Photolithography Devices, Methods, And Systemsgranted
- Pixel Configuration And Surface Treatment In A Transparent Displaygranted
- Nanoprinting Device, Materials And Methodapplication
- Maskless Photolithography Devices, Methods, And Systemsapplication
- Optical Photoresist Photolithography Method And Transparent Illumination Deviceapplication
- 3D Nanoprinting Device, Method, And Systemsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.